Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters, LLC

Deep Remission, Top-Down Treatment Strategies and Real-World Data in Patients with UC: An Interactive and Innovative Case Series

Access Activity

Overview / Abstract:

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endoscopic remission) with the objective of preventing structural damage and disability. Conventional therapies have not been uniformly effective in achieving these aims, necessitating augmentation with steroids and carrying adverse risk often requiring discontinuation.

There has been an exponential growth in the pursuits of better targeted therapy to optimize IBD clinical outcomes. IBD therapies that explore new targets and inflammatory pathways are emerging to address the current treatment gaps observed with conventional and biologic therapies.

In this archive from a CME Outfitters symposium, expert faculty will guide learners through patient cases using an interactive infographic to explain the importance of initiating early targeted biologic therapy and provide evidence-based strategies to take action to achieve sustained remission and long-term clinical outcomes.


Jun 08, 2018


Clinical Laboratory CE, Dietetics / Dietitian CE, Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME


Online, Performance Improvement, Podcast, Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Maria T. Abreu, MD (Moderator)
Director, Crohn's & Colitis Center
Martin Kalser Chair in Gastroenterology
Professor of Medicine
Professor of Microbiology and Immunology
University of Miami Miller School of Medicine
Miami, FL

Arthur A. Kornbluth, MD
Clinical Professor of Medicine
Inflammatory Bowel Disease Center
Henry D. Janowitz Division of Gastroenterology
Mount Sinai School of Medicine
New York, NY

Miguel Regueiro, MD, FACP, FACG, AGAF
Professor of Medicine, Professor of Clinical and Translational Science
University of Pittsburgh School of Medicine
Associate Chief, Education
Division of Gastroenterology, Hepatology, and Nutrition
Clinical Medical Director of Inflmmatory Bowel Disease
Senior Medical Lead of Specialty Medical Homes
University of Pittsburgh Medical Center
Pittsburgh, PA

Sponsors / Supporters / Grant Providers

Takeda Pharmaceuticals, U.S.A., Inc.

Keywords / Search Terms

CME Outfitters, LLC ulcerative colitis, UC, colitis, gastroenterology, inflammatory disease, crohn's disease, IBD, inflammatory bowel disease, irritable bowel disease Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.